Share this article
Share this article has undergone multiple quantitative tests that demonstrate its filtration system effectively blocks passage of aerosolized viral particles such as SARS-CoV-2, the virus responsible for COVID-19. This would effectively mitigate cross-contamination and transmission of infectious aerosols. The filtration found in Thopaz+ can help provide a safeguard for patients and staff.
(PRNewsfoto/Medela LLC) We understand the critical need for a solution like Thopaz+ that can help healthcare professionals provide safer cardiothoracic drainage and reduce cross contamination as well as healthcare-associated infections (HAI), during the COVID-19 pandemic and beyond, said Melissa Gonzales, RN, BSN, executive vice president of Medela Americas. With its intuitive, easy-to-use design and filtration capabilities, Thopaz+ was developed to meet the evolving needs of healthcare professionals and patients, simplify use while improving health outcomes and reduce co
Digital chest drainage systems could help reduce COVID-19 spread, research shows
Dec 14 2020
Pioneering research, which reveals digital chest drains generate and distribute less aerosol generated particles compared to traditional water seal systems, has been published in the Seminars in Thoracic and Cardiovascular Surgery journal.
Medela’s Thopaz+ Digital Chest Drainage and Monitoring System
The research was led by a team of thoracic consultants from Guy’s and St Thomas’ NHS Foundation Trust – home to one of the largest lung cancer practices in the UK.
At the start of the pandemic there was limited evidence about the spread of COVID-19 via chest drains which led to uncertainty within the thoracic community about the best medical device to use.